Valuation: Elutia Inc.

Market Cap 39.96M 36.4M 33.54M 30.51M 57.23M 3.7B 60.15M 408M 162M 2.02B 150M 147M 6.34B P/E 2026 *
-1.36x
P/E 2027 * -1.43x
Enterprise Value 39.96M 36.4M 33.54M 30.51M 57.23M 3.7B 60.15M 408M 162M 2.02B 150M 147M 6.34B EV / Sales 2026 *
5.33x
EV / Sales 2027 * 9.29x
Free-Float
85.22%
Yield 2026 *
-
Yield 2027 * -
1 day+11.12%
1 week+9.77%
Current month+7.53%
1 month+9.39%
3 months-5.34%
6 months-24.99%
Current year+29.94%
1 week 0.79
Extreme 0.7908
0.92
1 month 0.7
Extreme 0.7036
0.96
Current year 0.6
Extreme 0.6019
1.38
1 year 0.5
Extreme 0.5
1.38
3 years 0.5
Extreme 0.5
5.24
5 years 0.5
Extreme 0.5
9.01
10 years 0.5
Extreme 0.5
18.2
Manager TitleAgeSince
Chief Executive Officer 54 21/06/2022
Chief Operating Officer 52 -
Director of Finance/CFO 58 28/09/2020
Director TitleAgeSince
Chairman 65 01/11/2015
Director/Board Member 54 01/11/2015
Director/Board Member 70 01/09/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 A Exercice

Founder

63,884 0.1445%
9/10/26 A Exercice

Founder

29,269 0.0662%
9/10/26 A Exercice

Chief Financial Officer

29,486 0.0667%
Change 5-day change 1-year change 3-year change Capi.($)
+11.12%+9.77%+52.53%-44.78% 39.96M
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average +1.41%-3.30%+27.77%+63.60% 407B
Weighted average by Cap. +0.30%-5.19%+26.02%+87.87%

Financials

2026 *2027 *
Net sales 7.5M 6.83M 6.29M 5.73M 10.74M 695M 11.29M 76.61M 30.45M 379M 28.14M 27.55M 1.19B 4.3M 3.92M 3.61M 3.28M 6.16M 398M 6.47M 43.92M 17.46M 217M 16.13M 15.79M 683M
Net income -27.3M -24.86M -22.91M -20.84M -39.1M -2.53B -41.09M -279M -111M -1.38B -102M -100M -4.33B -23.6M -21.49M -19.81M -18.02M -33.8M -2.19B -35.52M -241M -95.81M -1.19B -88.55M -86.68M -3.75B
Net Debt - -
Projected Income Statement - Annual - Elutia Inc.
Logo Elutia Inc.
Elutia Inc. is a commercial-stage company developing proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. Its cardiovascular biomatrix portfolio spans pericardial closure, intracardiac tissue repair, and vascular reconstruction. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. Its cardiovascular products are specifically designed to provide immediate structural support while promoting tissue regeneration, cellular infiltration, and natural integration over time. It is focused on developing NXT-41x, an antibiotic-eluting biomatrix designed to address post-operative infection. The NXT-41x product is designed to provide soft-tissue reinforcement while locally delivering antibiotics locally to inhibit bacterial colonization at the surgical site.
Employees
26
Date Price Change Volume
20/11/26 $0.9001 +11.12% 83,880
19/11/26 $0.8100 -2.41% 20,732
18/11/26 $0.8300 -2.80% 14,519
17/11/26 $0.8539 +3.77% 49,962
16/11/26 $0.8229 +0.35% 53,867
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9001USD
Average target price
5.000USD
Spread / Average Target
+455.49%
  1. Stock Market
  2. Stocks
  3. ELUT Stock